olaparib targets prostate cancer mutations Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer. Phosphate-binder therapy does not reduce mortality ...
The medication may represent a new treatment option for dialysis patients, researchers concluded. A team led by Rong Wang, MD, of Shandong Provincial Hospital in Shandong, China, analyzed 8 randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback